Global Medical Equipment Company 100 announced the 34th 7 Chinese companies on the list!

Recently, QMED, a foreign authoritative third-party website, recently released the 2019 List of Top 100 Medical Device Companies, which ranks global medical device companies based on their 2019 revenue.
statistics, the top 10 medical device companies in the total revenue of 194.428 billion U.S. dollars, a total of 51 medical device companies worldwide revenue of more than 1 billion U.S. dollars.
, the change in the ranking of the world's top medical device companies also reflects the changes in the competitive landscape in the medical device industry in 2019.
's latest 2019 top 100 ranking of medical device companies (revenue unit: millions of dollars) the world's top medical device ranking changes significantly According to the ranking situation, Medtron remains firmly in the top position, with $30,891 million at the top.
the top 10 companies in the world's top 100 medical device companies have changed significantly compared to the top 100 in annual revenue in 2018.
Medtron, Johnson and Johnson, GE and Fessenjus are consistent with 2018 on the 2019 list of global medical device companies TOP10, and it's worth noting that Abbott and BD have all risen significantly.
10. Steck 2019 Total Revenue: $14.884 billion Last year Ranked: 9 As one of the world's largest orthopaedic medical device companies, Steck specializes in the development, production and sale of medical products.
products include implants for joint replacement and trauma surgery; surgical instruments and surgical navigation systems; endoscopes and communication systems; patient management, emergency medical devices; neurosurgery, nerve and spinal cord devices; and other medical device products for a variety of medical professions.
revenue for 2019 was $14.884 billion, up 9.43 percent from a year earlier, according to the latest financial results.
growth was steady in all sectors of the business, with orthopaedics up 5.2% year-on-year, medical surgery up 8.8% year-on-year, and neuroscolons growing rapidly, up 19.2% year-on-year.
In mid-2019, Steck's acquisition has accelerated, and the rapid growth of the neuroscolons business has been directly facilitated by the acquisition of Mobile Diagnostic Imaging Company Mobius and the interventional radiological robot Navigator Cardan.
addition, Steck has been making a number of acquisitions of OrthoSpace and Wright Medical Group in orthopaedics and minimally invasive surgery.
9. Philips Total Revenue 2019: $14.606 billion Last year Ranking: 3 Philips Healthcare restructured in January 2019 to shift the sleep and breathing portion from personal health to the new connected healthcare division and medical information to diagnostics and treatments.
under the new structure, Philips has three departments: Diagnostics and Treatment, Insurance and Personal Health.
2019, Philips' total revenue was $14.606 billion, up 9% year-on-year.
two core medical businesses in China, with the Diagnostics and Therapeutics Division up 10% YoY and the Joint Insurance Division up 8% YoY.
it is understood that by 2020, Philips will focus on the development of precision diagnostic and image-based minimally invasive solutions, as well as patient care solutions across hospitals and beyond.
.8. Gardner's total revenue for 2019: $15,749 million Last year: 7 as the top three U.S. drug circulation companies, it officially updated the Chinese brand name "Gardno" in China in March 2019.
.
it's been four years since Cardinal Health bought Johnson and Johnson's Cordis for $1.94 billion, the company is still struggling to meet challenges related to manufacturers of stents, balloons and other interventional heart products.
In August 2019, Mike Kaufmann, Chief Executive Officer of Gardner, said on a conference call, "Cardinal Health has introduced a new sales structure for its healthcare business and is in the process of transforming its manufacturing, supply chain and data capabilities."
2019, Gardner's focus remains on the execution and acquisition of products.
, Gardner's 2019 results have not yet been released and business growth is unclear.
7. Siemens Total Revenue 2019: $16.090 billion Ranking last year: 6 Siemens Medical is a major manufacturer of medical imaging systems, including computer fault imaging, mr. Magnetic Resonance Imaging, Molecular Imaging, X-rays, and Ultrasound.
company also produces angiosis systems for image-guided therapy, mobile c-arms and hybrid operating rooms, as well as diagnostic testing systems, and other services including software and clinical counseling.
Siemens reported total revenue of $16,090 million in 2019, up 8 percent from a year earlier.
's imaging business grew by 10 per cent, its diagnostic business by 4 per cent and its clinical treatment business by 9 per cent.
in mid-2019, Siemens acquired Corindus, a global technology leader in robotic-assisted vascular intervention in the United States, and ECG, a U.S. medical consulting firm, to strengthen its clinical practice and medical services.
6.BD 2019 Total Revenue: $17.290 billion Ranking last year: 16BD is one of the world's largest medical technology companies for the development, production and sale of medical devices, medical systems and reagents, focusing on improving drug transmission, improving the quality and speed of diagnosis of infectious diseases and cancers, and advancing the development and production of new drugs and vaccines.
2019 results, BD reported total revenue of $17.290 billion, up 8% year-on-year.
, the life sciences business fell slightly, down 0.7 per cent year-on-year, while the rest of the healthcare and intervention sectors grew 5.2 per cent and 29.3 per cent, respectively.
5. Fessenyus 2019 Total Revenue: $19.264 billion Last year Ranking: 5 Fessenyus Healthcare is the world's largest medical device company in chronic kidney care, providing dialysis products and services to more than 300,000 patients worldwide.
company has become a global leader in dialysis.
the biggest news about Fessenjus was that in February the U.S. Federal Trade Commission approved the merger of Fiesenjus of Germany and NxStage Medical Inc., a U.S. home dialysis equipment maker.
the U.S. Federal Trade Commission said the two companies agreed to sell NxStage's blood vessel set business in order to approve the $2 billion deal.
July 2019, the company's stock was hit hard by news that the Trump administration was planning to overhaul the kidney treatment market and seek to reduce the federal government's $100 billion annual cost of kidney care.
the strategy involves a new payment model from the U.S. Department of Health and Human Services, which aims to move patients from a hemodialysis clinic in Fessenjus to their homes for treatment, and the Department of Health and Human Services plans to increase prevention and screening for kidney disease.
.GE's total revenue for 2019: $19.942 billion Last year Ranking: 4GE Healthcare is still not listed independently after a turbulent year.
2019 results, GE reported total annual revenue of $19,942 million, up 1% year-on-year.
kieran Murphy, GE Healthcare's global president and executive director, said GE Healthcare's main job now is to invest resources in working with next-generation companies to help change the way doctors work and achieve more accurate patient care.
2019 total revenue: $19,952 million Last year: 112019, Abbott achieved total revenue of $19,952 million, up 6 per cent year-on-year.
jumped from 11th place in 2018 to third place, mainly because of the rapid growth of its diabetes business, which grew 30.6 percent year-on-year.
, the diagnostics business grew by 2.9% year-on-year and the medical device business by 7.6% year-on-year.
2020, Abbott's CEO, Michael White, will officially step down at the end of March, taking over from Robert Ford, Abbott's president and chief operating officer.
it is understood that Mr Abbott will continue his merger and acquisition efforts in 2020.
2. Johnson and Johnson's total revenue for 2019: $25,963 million Last year: 2 Johnson and Johnson Medical entered one of the hottest areas of medical technology during the year, spending $3.4 billion on Aurris Health and its Monarch Robotic Assisted Bronchoscopy platform, supplementing the Robotic Assisted General Surgery Program with Verb Surgical and Orthopaedic Surgery, and acquiring an orthopaedic platform.
2019, the company's total revenue was $25,963 million, down 3.8 percent from a year earlier.
main reason is that Johnson and Johnson continues to restructure its medical device division, divesting two assets: selling its advanced disinfection product business to Fortive for $2.8 billion and selling Its Lifecan blood glucose monitoring subsidiary Platinum Equity for $2.1 billion.
2019 total revenue: $30,891 million Last year: In 2019, Medtron achieved annual revenue of $30,891 million, up 2% year-on-year.
mainly due to the larger growth in its diabetes and restorative therapy businesses, at 12% and 6%, respectively.
In August 2019, Medtron announced a CEO succession plan, and Medtron CEO Omar Ishrak will retire at the end of fiscal 2020 after nearly nine years at the helm.
, Geoff Martha, the current president of the company's Recovery Therapy Business Unit (RTG), is the new president of Medtron.
that in 2020, Medtron will continue to implement the three core strategies of therapeutic innovation, globalization and economic value.
7 Chinese medical device companies on the list in fact, in 2019 China's domestic medical device industry development is also very rapid, a large number of enterprises listed after the listing have achieved good results.
in this top 100 list, Meirui Medical, Xinhua Medical, Lepu Medical, Minimally Invascope Medical, Fish Leap Medical and other 7 medical device enterprises are on the list, and half of the enterprises are in the forefront.
can be proud to say that domestic medical device enterprises are rising.
article Source: QMED, Medical Device Dealers Alliance, Medical Coffee, IVD Information.